NIG
CRL icon

NFJ Investment Group’s Charles River Laboratories CRL Stock Holding History

NFJ Investment Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-56
Closed -$10.3K – 288
2024
Q4 		$10.3K Hold
56
– – ﹤0.01% 266
2024
Q3 		$11K Sell
56
-28,192
-100% -$5.86M ﹤0.01% 267
2024
Q2 		$5.84M Sell
28,248
-3,817
-12% -$865K 0.18% 125
2024
Q1 		$8.69M Sell
32,065
-6,452
-17% -$1.54M 0.24% 114
2023
Q4 		$9.11M Sell
38,517
-6,779
-15% -$1.33M 0.25% 108
2023
Q3 		$8.88M Sell
45,296
-513
-1% -$105K 0.26% 99
2023
Q2 		$9.63M Buy
45,809
+65
+0.1% +$12.9K 0.26% 115
2023
Q1 		$9.23M Sell
45,744
-504
-1% -$114K 0.25% 130
2022
Q4 		$10.1M Sell
46,248
-24,291
-34% -$5.3M 0.26% 123
2022
Q3 		$11.4M Buy
+70,539
New +$15.2M 0.3% 119

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

NFJ Investment Group's CRL Position: Q1 2025 in Review

NFJ Investment Group sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 56 shares — an estimated $10.3K sold.

NFJ Investment Group first reported a position in CRL in Q3 2022 and held it in 10 quarters. The position peaked at $11.4M in Q3 2022. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • NFJ Investment Group reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • NFJ Investment Group sold 56 Charles River Laboratories shares in Q1 2025, an estimated $10.3K.
  • NFJ Investment Group first reported a position in Charles River Laboratories in Q3 2022 and held it in 10 quarters.
  • NFJ Investment Group's Charles River Laboratories position peaked at $11.4M in Q3 2022.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on NFJ Investment Group's 13F filing for Q1 2025, filed 15 May 2025.